Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

// request.cf · coarse context

A page that knows where it met you.

Only coarse request metadata is shown. This demo does not display or persist visitor IP addresses.

Country
US
Cloudflare location
CMH
Connection
HTTP/2
Language
Not provided

Ray ID: a2270e941afe0acb

Jump to content

// Workers AI · dad joke modeWhat did EpiBone say to the marrow? You're a cell-abration.

From Wikipedia, the free encyclopedia

EpiBone is a biomedical engineering company that is developing technology to create bone tissue from a patient's mesenchymal stem cells in vitro for use in bone grafts.[1][2]

History

[edit]

EpiBone was founded in 2013 by Nina Tandon and Sarindr “Ik” Bhumiratana in New York City.[3] The company’s technology derives from research in bone and osteochondral tissue engineering at Columbia University.[4][failed verification]

See also

[edit]

References

[edit]
  1. "This Woman's Revolutionary Startup Could Change 900,000 Surgeries A Year". Business Insider. Retrieved 2015-10-20.
  2. "EpiBone". Retrieved 2022-04-07.
  3. "This Startup Wants People to Grow Their Own Bone Transplants". Bloomberg.com. Archived from the original on 2022-12-03. Retrieved 2025-09-07.
  4. Murphy, Sean V.; Atala, Anthony (2016). Regenerative Medicine Technology: On-a-Chip Applications for Disease Modeling, Drug Discovery and Personalized Medicine. CRC Press. p. 407. ISBN 9781498711920.